Print page Print page
Switch language
The Capital Region of Denmark - a part of Copenhagen University Hospital

Ex vivo Release of Calcitonin Gene-Related Peptide from the Trigeminovascular System in Rodents

Research output: Contribution to journalJournal articlepeer-review


  1. Intravascular Lithotripsy-Assisted Transfemoral Transcatheter Aortic Valve Implantation

    Research output: Contribution to journalJournal articlepeer-review

  2. Real-time Monitoring of Mitochondrial Respiration in Cytokine-differentiated Human Primary T Cells

    Research output: Contribution to journalJournal articlepeer-review

  3. Pre-Chiasmatic, Single Injection of Autologous Blood to Induce Experimental Subarachnoid Hemorrhage in a Rat Model

    Research output: Contribution to journalJournal articlepeer-review

View graph of relations

Calcitonin gene-related peptide (CGRP) was first discovered in the 1980s as a splice variant from the calcitonin gene. Since its discovery, its role in migraine pathophysiology has been well established, first by its potent vasodilator properties and subsequently by its presence and function as a neurotransmitter in the sensory trigeminovascular system. The migraine-provoking ability of CGRP gave support to the pharma industry to develop monoclonal antibodies and antagonists inhibiting the effect of CGRP. A new treatment paradigm has proven effective in the prophylactic treatment of migraine. One of the useful tools to further understand migraine mechanisms is the ex vivo model of CGRP release from the trigeminovascular system. It is a relatively simple method that can be used with various pharmacological tools to achieve know-how to further develop new effective migraine treatments. The present protocol describes a CGRP release model and the technique to quantify the effect of pharmacological agents on the amount of CGRP released from the trigeminovascular system in rodents. A procedure describing the experimental approach from euthanasia to the measurement of protein levels is provided. The essential isolation of the trigeminal ganglion and the trigeminal nucleus caudalis from both mice and rats and the preparation of rat dura mater are described in detail. Furthermore, representative results from both species (rats and mice) are presented. The technique is a key tool to investigate the molecular mechanisms involved in migraine pathophysiology by using various pharmacological compounds and genetically modified animals.

Original languageEnglish
Article numbere63723
JournalJournal of visualized experiments : JoVE
Issue number183
Publication statusPublished - 2022

    Research areas

  • Animals, Calcitonin/metabolism, Calcitonin Gene-Related Peptide/metabolism, Mice, Migraine Disorders/drug therapy, Rats, Rodentia/metabolism, Trigeminal Ganglion/metabolism

ID: 79152649